Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Tuberculosis (TB)








Building Partnerships						Print
											PAGE 2 of 5
					**‹**View Table of Contents					Related Pages
										Return to TB Elimination ChampionsOpen All Close All
Tom AndrewsTom Andrews, Building Partnerships
Since 2008, the downtown metropolitan-Atlanta area has struggled to control an outbreak of TB among people experiencing homelessness. People experiencing homelessness face many challenges throughout their day. They face obstacles to obtaining food, adequate shelter, and health care. Behavioral and mental health challenges can also present a unique set of problems when trying to identify those with TB infection and disease and provide adequate treatment. Infection control within homeless service agencies, particularly overnight shelters, is also challenging to achieve.
As the outbreak progressed in 2014, it became apparent that Atlanta service providers needed to come together to reduce the burden of disease. Tom Andrews, as the President of the largest Health Care for the Homeless grant recipient in Atlanta, led the effort to establish the Metro Atlanta TB Task Force. He invited shelter directors, clinic managers, representatives from the State of Georgia, City of Atlanta, Fulton and DeKalb Counties, Emory University, Grady Health, Atlanta-area HUD-funded Continuum of Care representative, and staff from Mercy Care.
Through this collaboration, Dr. Neela Goswami from Emory led an effort to develop new TB guidelines for the city of Atlanta. A shelter check list was established so that each overnight facility could work toward reducing risk. Dr. Rose Sales from Department of Public Health and Dr. Goswami were also instrumental in the development of educational materials that were distributed city-wide. The health department and Mercy Care began to share the burden of screening patients for active TB disease and testing for latent TB infection. Systems were also put in place to notify people when they were due for additional screening by the health department.
The outbreak is not over, but the incident cases are greatly reduced. There were 44 active TB cases identified among the shelter population in 2014. This has decreased to 16 active TB cases in 2015. Four of the cases in 2015 were diagnosed as a result of shelter-based screening protocols. Tom’s leadership, efforts in establishing communication between service agencies and health departments, and relentless persistence brought everyone together to reduce TB transmission and work toward ending the outbreak completely.Ann CroninAnn Cronin, Building Partnerships
Ann Cronin is DTBE’s Associate Director for Policy. She addresses the numerous policy and programmatic challenges confronting domestic TB control and prevention. In 2015, Ann and her team’s dedication and passion for domestic TB control efforts intensified and were channeled into a single, critical document, the *National Action Plan for Combating Multidrug-resistant Tuberculosis**(MDR TB*) (NAP). Although no funding was identified to support the document at the time of its launch, the NAP provided an essential roadmap for our collective efforts to address multidrug-resistant (MDR) TB. The plan addresses MDR TB both domestically and globally, for the next five years.
Ann and her team were instrumental in the development and launch of the NAP’s first goal. The first goal of the NAP is to strengthen domestic capacity to combat MDR TB. Throughout the development of the NAP, the team successfully built new partnerships and engaged existing partners to provide technical advice on the relevant content. Ann sought guidance from DTBE’s partners. One of the document’s strengths is in the collective response from the partnership that Ann and her team worked to achieve.
Despite the emphasis on MDR TB in its title, Ann successfully expanded the focus of the document to include drug-resistant (DR) TB. This expanded focus recognizes the increasing numbers of individuals with mono-resistant TB (resistant to INH, primarily). It would not have been included had Ann and her team not listened to partners who pushed for and effectively argued for this expanded scope.
The NAP outlines significant milestones for achieving the stated activities for strengthening domestic capacity to combat DR TB. The milestones include:
Upgrade TB surveillance to ensure complete and accurate detection of DR TB;
Strengthen state and local capacity to prevent transmission of DR TB; and
Ensure that patients with DR TB receive treatment until cured.Each of these milestones, and the steps required to achieve successful execution, will continue to require a commitment to partnerships and maximizing scarce or limited resources. This effort to address and support domestic TB control efforts would not have had the visibility and significant infusion of national-level significance without the work of Ann, a true TB Elimination Champion.Maureen DonovanMaureen Donovan, Building Partnerships
Maureen Donovan, RN, MA has been a nurse consultant with the State of Maryland Center for TB Control and Prevention for over 20 years.  During that time, her sensitivity to the needs of nursing and outreach staff at city and county health departments has created successful working relationships between the local health departments and the state TB program.
Building a functional and sustainable relationship between local health departments and state health departments is critical to the goal of TB elimination in the United States. These partnerships do not become sustainable through formal contracts or memorandums of understanding. They stand the test of time through the mutual understanding that state consultants are there to assist and support local programs. Maureen’s efforts have done much to establish this base of respect and trust in Maryland.
Maureen has worked to strengthen partnerships in Maryland by providing employees new to local TB programs with at least one personal, face-to-face orientation session. During the session, basic policies and procedures are reviewed. In doing so, Maureen encourages those not familiar with TB case management to call and discuss issues and concerns. She has coordinated regional training activities to encourage networking among colleagues. She has supported case and cohort reviews of all TB patients diagnosed and cared for in the state. Maureen has also led the training of local health departments on the use of IGRA testing in partnership with the Maryland Mycobacteriology Laboratory staff.Harrington Hospital TB ClinicHarrington Hospital
Located between Boston and Springfield, MA, Harrington Hospital’s TB Clinic has managed to survive during times when major budget cuts in public health funding have led to the closure of other clinics throughout the state. This is due to the unique collaborations between a not-for-profit community-based hospital, the Massachusetts Department of Public Health TB Division, and eight local town boards of health (LBOH).
Despite significant budget cuts at both state and federal levels, Harrington Hospital has maintained their pledge to the prevention and control of TB. The clinic is staffed on a part-time basis by 3 people: an MD, a medical office assistant, and an RN. The TB Clinic RN also serves as the Public Health RN for the eight LBOH’s. Because of this, patients can be seen in both the clinic and home setting for Directly Observed Therapy (DOT) visits and LBOH RN case management. This allows the clinic nurse to develop holistic plans of care for TB patients and their families. The physical, emotional, psychological, and cultural needs of patients are taken into consideration when plans are developed.
The preventive health/TB clinic is also the Vaccine for Children Program (VFC) provider on behalf of the eight LBOH’s. This allows Harrington Hospital to provide much needed vaccinations and assistance with health care coverage to a population that is often medically underserved. The symbiotic relationship between the hospital’s TB clinic and local and state public health departments fosters engagements of local church and community organizations. These organizations are often called upon for assistance with other patient and family needs, such as food, clothing, and shelter. This local TB prevention and treatment program is an asset to the community.Houston Bureau of TB African-American Project TeamHouston Bureau of TB African-American Project Team, Building Partnerships
The Houston Bureau of TB African-American Project Team has been at the forefront of providing TB education to agencies located within the city’s African-American community. Since the team’s inception, a significant decline in TB among the African-American population has been reported, from 34% to 26%, from 2008 to 2015, respectively.
Each year, the Team comes up with innovative methods to reach out to the African-American community to more effectively fight TB. The team’s activities include analyzing genotype patterns for clustered cases in the Houston community, then targeting education and training. The team has identified new agencies to partner with, such as drug abuse centers, shelters, churches, and affordable housing programs. Additionally, the team provides education and tests for TB at targeted testing events in the community, with ever increasing numbers of patients identified and treated for latent TB infection.
The Team makes it a priority to share knowledge and lessons learned with others; they have taught others to target education efforts based on the local epidemiology. They have developed training tools that other programs can benefit from. The team has also worked with federal, state, and local governments to maintain funding. They continue to generate high energy by being motivated, innovative, and dedicated.Karen JohnsonKaren Johnson, Building Partnerships
Karen Johnson, RN, is an Immunization Coordinator/Public Health Nurse Sr. at the Virginia Department of Health, Rappahannock-Rapidan Health District. She has built strong community partnerships through coordination of care with the local Department of Social Services and primary care physicians. These relationships have assisted in providing food and shelter to patients in need.
Karen is always willing to case manage unique cases that need extra coordination of resources and education. She assists with care for the mental and physical needs of each patient. This has involved reaching out to and collaborating care with the local Community Services Board. Karen has gone grocery shopping and visited the local food pantry to support patients. She works with partners to find long-term housing solutions for those who need assistance.
Focusing on prevention strategies has been a key component of Karen’s practice. She has coordinated the update of testing protocols with local home health agencies, daycare centers, and assisted living facilities. She has made herself available to these partners and provided them with additional training, as needed.
Karen has maximized resources and expanded testing and treatment by helping with other county intakes within the Rappahannock-Rapidan Health District. She has conducted DOT visits and provided coordination of care. Karen also supports infection control by coordinating care with local emergency rooms. She provides assistance with isolation precautions and isolation termination clearances for the hospitals and emergency medical services. In addition to these things, she coordinates discharge care for TB patients to ensure medication delivery and continued services.Rotary Clubs of Austin University Area, Reynosa, and Nuevo Laredo ReformaRotary Clubs of Austin University Area, Reynosa, and Nuevo Laredo Reforma, Building Partnerships
The Rio Grande border area has one of the highest rates of TB in either Mexico or the United States. With over 65 million annual border crossings between Mexico and Texas, this creates an environment ripe for a bi-national TB crisis.
Three bi-national rotary clubs and two state governments worked together to save lives along the 1200 mile border in Mexico from California to Texas. The Rotary Clubs of Reynosa and Nuevo Laredo Reforma lobbied the Tamaulipas State Governor and Minister of Health for a new building dedicated to the diagnosis and treatment of TB. The State of Texas provided guidance, advice, and support. The Rotary Clubs of Austin University Area and Reynosa provided the diagnostic equipment, supplies, and an extensive public education effort. These efforts were funded by a Rotary Foundation “Health, Hunger, and Humanities” grant.
The partners developed an integrated, four-step effort for the identification and treatment of TB:
Identification**:** To get people with TB symptoms to come in for testing, a community education program was developed to reduce the stigma of TB.
Evaluation**:** When a person with TB symptoms arrives in the clinic, a digital X-ray is taken to provide faster results. These results can then be quickly shared with health care professionals.
Diagnosis: Sputum smears are submitted to confirm the TB diagnosis and sputum is cultured to determine drug sensitivities.
Treatment: To assure successful treatment, Direct Observation of Therapy (DOT) is provided. To assist with treatment, consultation with a nutritionist and a psychologist are also provided.The clinic has achieved remarkable results. According to Dr. Monserrato Garcia, head of the State of Tamaulipas Tuberculous Unit, the area has seen about a 60% decline in the number of patients who have stopped TB treatment. The rate of death from TB disease has dropped by almost 80%.
To learn more about this project, visit http://www.austinuniversityrotary.org/Page/our-projects.Teresa RuggTeresa Rugg, Building Partnerships
As the Executive Director and Board Secretary of TB Photovoice, Teresa Rugg is a shining example of a TB Champion. TB Photovoice is an organization that aims to improve the overall health of individuals and communities by using images, stories, and dialogue to give a powerful voice to people affected by TB.  Through her work with TB Photovoice, Teresa has built partnerships with TB survivors and their families, health departments, media outlets, TB organizations, anti-poverty organizations, schools, churches, and a network of technology professionals.
TB Photovoice is more than an outlet for TB survivors to share their stories. Most recently, with funding from the Firland Foundation, TB Photovoice****completed a project, TB Voices. TB Voices focused on TB survivors or those affected by TB in a two-county area of Washington State.  With great sensitivity and respect, Teresa and the leadership of TB Photovoice have identified recurrent themes in each story. These themes have helped develop an innovative TB awareness, prevention, and support campaign. Rugg’s vision to create an interactive website and a social media forum for people impacted by TB was realized in the fall of 2015 through a partnership with the technology nonprofit Seattle GiveCamp.
Teresa travels globally to present TB survivor stories and share the mission of TB Photovoice. She is dedicated to spreading the message to as many people as she can, building partnerships along the way. Recently, she helped promote Stop TB Partnership’s new guide to end language that stigmatizes people with TB disease.Texas Department of State Health Services Mycobacteriology Laboratory, Austin, TexasFor the past two years, the Texas Department of State Health Services (TDSHS) Laboratory in Austin, Texas has provided full service TB testing for Louisiana’s public health system. These services have included AFB smear, rapid direct testing, culture, identification of positive cultures, drug susceptibility testing (DST) of *M*. *tuberculosis* complex (MTBC) isolates, and MTBC genotype referral.
This is the not the first time the TDSHS Mycobacteriology Laboratory has assisted Louisiana in TB testing. In September 2005, the Louisiana TB Control Program asked the TDSHS Laboratory to perform TB testing for Louisiana’s public health system after Hurricane Katrina. The hurricane had forced the state’s only public health laboratory (PHL) with capacity for TB testing to shut down.
The staff in the TDSHS Mycobacteriology Laboratory readily accepted the work in order to assist Louisiana. Because this event was an emergency, administrative duties that accompanied specimen testing were very time-consuming. The TDSHS Mycobacteriology Laboratory spent a significant amount of time coordinating requests from Louisiana. They also assisted in directing specimens to the laboratory.
During 2007, in preparation for the Shreveport, Louisiana laboratory to open as the new state laboratory, the TDSHS Laboratory hosted technologists from the Shreveport regional laboratory for a week long mycobacteriology training. They also shipped unprocessed split specimens to Shreveport for several months to assist with validation of TB testing. The Shreveport laboratory was eventually accredited and implemented TB testing in March 2009. From September 2005 to 2009, the TDSHS Mycobacteriology Laboratory performed TB testing on over 16,000 clinical specimens from Louisiana. This was quite an accomplishment for the TDSHS Mycobacteriology Laboratory and staff.
One of the greatest lessons learned from this experience is the importance of partnerships. Having a well-established partnership like the one that now exists between Texas and Louisiana is important in preparing for future emergencies.

									Supporting TB Control**›****Building Partnerships**Expanding Testing and TreatmentFocusing on PreventionMaximizing Resources
							
					
							Last Reviewed:  March 23, 2016						Source: 	Division of Tuberculosis Elimination
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue